A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria

Clinical Infectious Diseases

Volumn 41, Issue 4, 2005, Pages 425-432

  Ashley, Elizabeth A ^a,b,c   McGready, Rose ^a,b,c   Hutagalung, Robert ^a   Phaiphun, Lucy ^a   Slight, Thra ^a   Proux, Stephane ^a   Thwai, Kyaw Lay ^a   Barends, Marion ^a   Looareesuwan, Sornchai ^b   White, Nicholas J ^b,c   Nosten, François ^a,b,c  

^a SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEKIN; ARTESUNATE; DIHYDROARTEMISININ; DIHYDROARTEMISININ PLUS PIPERAQUINE; MEFLOQUINE; METHAQUALONE; PIPERAQUINE; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; CARDIOTOXICITY; CHILD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; EPIGASTRIC PAIN; FEBRILE CONVULSION; FEMALE; FEVER; FOLLOW UP; GENOTYPE; HEMATEMESIS; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MENINGISM; MORTALITY; MULTIDRUG RESISTANCE; NAUSEA; NEPHRITIS; PATIENT COMPLIANCE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RESPIRATORY TRACT INFECTION; SLEEP DISORDER; THAILAND; URTICARIA; VOMITING;

ADOLESCENT; ADULT; AGED; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MEFLOQUINE; MIDDLE AGED; PLASMODIUM FALCIPARUM; QUINOLINES; SESQUITERPENES;

EID: 23244447395     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/432011     Document Type: Article

References (15)

1. Denis MB, Davis TM, Hewitt S, et al. Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clin Infect Dis 2002; 35:1469-76.
2. Tran TH, Dolecek C, Pham PM, et al. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet 2004; 363:18-22.
3. Ashley EA, Krudsood S, Phaiphun L, et al. Dose optimization randomized controlled studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. J Infect Dis 2004; 190:773-82.
4. Qu FY. The antimalarial effects of piperaquine phosphate and sulphadoxine composite as tested in Hainan Island [in Chinese], Zhonghua Yi Xue Za Zhi 1981; 61:388-91.
5. White NJ. Antimalarial drug resistance and combination chemotherapy. Philos Trans R Soc Lond B Biol Sci 1999; 354:739-49 .
6. Luxemburger C, Thwai KL, White NJ, et al. The epidemiology of malaria in a Karen population on the western border of Thailand. Trans R Soc Trop Med Hyg 1996; 90:105-11.
7. World Health Organization. Severe falciparum malaria. Trans R Soc Trop Med Hyg 2000; 94(Suppl 1):S1-90.
8. Brockman A, Paul RE, Anderson TJ, et al. Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Am J Trop Med Hyg 1999; 60:14-21.
9. Luxemburger C, Nosten F, Raimond SD, Chongsuphajaisiddhi T, White NJ. Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria. Am J Trop Med Hyg 1995; 53:522-5.
10. Karunajeewa H, Lim C, Hung T, et al. Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria. Br J Clin Pharmacol 2004; 57:93-8.
11. Anker M, Black RE, Coldham C, et al. A standard verbal autopsy method for investigating causes of death in infants and children. WHO/CDS/CSR/ISR/99/4. Available at: http://www.who.int/entity/csr/resources/publications/surveillance/ whocdscsrisr994.pdf. Accessed 1 July 2005
12. Ioannidis JP, Lau J. Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. JAMA 2001; 285:437-43.
13. White N. Malaria. In: Zumla GCA, ed. Manson's tropical diseases. 21st ed. Edinburgh, Scotland: W.B. Saunders, 2003:1205-96.
14. White NJ. The assessment of antimalarial drug efficacy. Trends Parasitol 2002; 18:458-64.
15. Price RN, Nosten F, Luxemburger C, et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet 1996; 347:1654-8.